Product Description

Keytruda Injection 100mg/4ml contains Pembrolizumab, a programmed death receptor-1 (PD-1) blocking monoclonal antibody used to treat various cancers, including melanoma, non-small cell lung cancer (NSCLC), head and neck cancer, Hodgkin lymphoma, and several other advanced malignancies.

Product Overview

Product Name: Keytruda Injection 100mg/4ml

Generic Name: Pembrolizumab

Strength: 100mg/4ml

Form: Solution for Intravenous Infusion

Pack Size: 4ml Vial

Used For: Treatment of multiple advanced cancers

Prescription Required: Yes

Ingredients & How They Work

Each 4ml vial contains Pembrolizumab 100mg, a monoclonal antibody that blocks the PD-1 receptor on T-cells, enabling the immune system to recognize and destroy cancer cells more effectively.

Key Benefits

• Treats multiple advanced cancers
• Enhances the body's immune response against cancer
• Targeted immunotherapy
• May improve long-term survival in eligible patients
• Intravenous hospital-based treatment

How to Use

Administer as an intravenous infusion by a qualified healthcare professional according to your oncologist's prescribed treatment schedule.

Side Effects & Precautions

Possible Side Effects

• Fatigue
• Skin rash
• Diarrhea
• Nausea
• Immune-related inflammation affecting organs

Precautions

• Use only under the supervision of an oncologist.
• Regular monitoring of liver, kidney, and thyroid function is recommended.
• Report persistent cough, diarrhea, or severe skin reactions immediately.
• Inform your healthcare provider about any autoimmune disorders.

Storage Instructions

Store in a refrigerator at 2°C to 8°C. Do not freeze. Protect from light.